Skip to main content

Advertisement

Table 1 Level of Hyaluronate in subgroup of chronic hepatitis B comparing to normal control

From: Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B

Patient Groups Subgroups n Mean ± SD P value*
Normal control   28 20.4 ± 15.4  
Chronic hepatitis B subgroups (degree of fibrosis) Stage 0–2 54 24.7 ± 31.9 0.69
  Stage 3–5 11 309.7 ± 143.5 <0.001
Chronic hepatitis B subgroups (degree of inflammation) Grade 0–8 54 39.6 ± 74.2 0.10
  Grade ≥ 9 11 236.5 ± 188.7 0.003
  1. *Statistical difference between serum hyaluronate of different groups compared with normal controls.